Added to YB: 2026-03-10
Pitch date: 2026-03-07
OMDA [neutral]
Omada Health, Inc.
+1.89%
current return
Author Info
MVC Investing is a long-term investor. BSc in Economics, MSc in Finance. Equity Analyst with a focus on Fundamental Analysis and Valuation. Sign up for the newsletter.
Company Info
Omada Health, Inc. provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.
Market Cap
$827.9M
Pitch Price
$13.76
Price Target
N/A
Dividend
N/A
EV/EBITDA
-99.59
P/E
-40.29
EV/Sales
2.33
Sector
Health Care Providers and Services
Category
growth
Omada Health (OMDA): Q4 2025 Earnings Review
OMDA (earnings): Q4 rev $75.8M vs $69.7M est (+58% YoY), first GAAP profit w/ EPS $0.08 vs $(0.05) est, adj EBITDA $8.5M vs $1.6M est (11.2% margin), FCF $20.1M vs $1.7M est. FY25: $260M rev (+53%), adj EBITDA $6.5M vs $(29.4)M prior, 40% incremental rev→EBITDA conversion. 2026 guide: $312-322M rev, $7-15M EBITDA (conservative, excludes GLP-1 prescribing/Flex/cholesterol). 886K members (+55% YoY), 25M+ covered lives (only 3.5% penetrated). GLP-1 tailwind: 150K members supported, 17% of base. Mgmt targets 20%+ EBITDA margin long-term; trading ~20x 2028 EV/EBITDA on consensus, but author sees 15%+ margins vs 6% est→single-digit fwd multiple. Risk: customer concentration >50% from top 2 partners. $222M cash, no debt.
Read full article (13 min)